Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Censoring Survival Data01:09

Censoring Survival Data

539
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
539
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

732
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
732
Conservation of Small Populations02:04

Conservation of Small Populations

17.1K
Small population sizes put a species at extreme risk of extinction due to a lack of variation, and a consequent decrease in adaptability. This weakens the chances of survival under pressures such as climate change, competition from other species, or new diseases. Large populations are more likely to survive pressures such as these, as such populations are more likely to harbor individuals that have genetic variants that are adaptive under new stresses. Small populations are much less...
17.1K
Survival Tree01:19

Survival Tree

418
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
418
Survival Curves01:18

Survival Curves

696
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
696
What is Population Genetics?01:25

What is Population Genetics?

64.6K
A population is composed of members of the same species that simultaneously live and interact in the same area. When individuals in a population breed, they pass down their genes to their offspring. Many of these genes are polymorphic, meaning that they occur in multiple variants. Such variations of a gene are referred to as alleles. The collective set of all the alleles within a population is known as the gene pool.
64.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A real-world preventive primary care model for cardiorenal metabolic disease: clinical impact of a personalised care approach in Harrow, North West London.

BMC nephrology·2026
Same author

Leveraging External Data for Testing Experimental Therapies with Biomarker Interactions in Randomized Clinical Trials.

Biometrika·2026
Same author

Large-scale analogue quantum simulation using atom dot arrays.

Nature·2026
Same author

Role of Resistive Index to Differentiate between Prerenal Acute Kidney Injury and Acute Tubular Necrosis.

Mymensingh medical journal : MMJ·2025
Same author

Classification of glioma grade and Ki-67 level prediction in MRI data: A SHAP-driven interpretation.

Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society·2025
Same author

High-fidelity sub-microsecond single-shot electron spin readout above 3.5 K.

Nature communications·2025
Same journal

The ethical obligation to use positive trial results.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

Lorlatinib: The Crown Jewel of ALK Inhibitors.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

TROP2-Directed Antibody Drug Conjugates: New First-Line Treatment for All Patients with Advanced Triple-Negative Breast Cancer?

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

When artificial intelligence learns to abstain: towards clinically responsible diagnostic support in liver pathology.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

PRMT5 inhibitors in MTAP loss NSCLC with actionable genomic alterations: a new kid on the block?

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

Refining decision making in hormone receptor-positive early-stage breast cancer: moving from static to dynamic.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
See all related articles

Related Experiment Video

Updated: Jan 27, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.8K

Divining responder populations from survival data.

R Rahman1, S Ventz2, G Fell3

  • 1Department of Radiation Oncology, Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston; Department of Radiation Oncology, Harvard Medical School, Boston.

Annals of Oncology : Official Journal of the European Society for Medical Oncology
|March 13, 2019
PubMed
Summary
This summary is machine-generated.

Biomarkers predicting treatment response are key to precision medicine. This study shows how predictive and prognostic biomarkers can cause time-varying treatment effects in clinical trials, aiding biomarker discovery.

Keywords:
biomarkerssubgroup effectssurvival analysistrial simulations

More Related Videos

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy
07:02

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy

Published on: January 19, 2019

6.9K
Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions
05:18

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions

Published on: July 22, 2016

8.9K

Related Experiment Videos

Last Updated: Jan 27, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.8K
Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy
07:02

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy

Published on: January 19, 2019

6.9K
Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions
05:18

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions

Published on: July 22, 2016

8.9K

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Genomic Medicine

Background:

  • Biomarkers predicting treatment response are crucial for precision medicine and clinical trial efficiency.
  • Many trials enroll unselected populations, potentially masking subgroup-specific treatment effects.
  • Time-varying treatment effects in unselected trials may indicate identifiable responder subpopulations with associated biomarkers.

Purpose of the Study:

  • To simulate and demonstrate how biomarker subgroups with prognostic and predictive value can manifest as time-dependent treatment effects.
  • To illustrate this phenomenon using a real-world example from a published clinical trial (RTOG 9402).
  • To present a quantitative framework for analyzing survival data and prioritizing predictive biomarker hypotheses.

Main Methods:

  • Simulated clinical trial scenarios with varying biomarker prevalence and associations.
  • Re-analyzed data from RTOG 9402, focusing on time-dependent effects linked to biomarkers (1p/19q co-deletion, IDH mutation).
  • Developed statistical models using The Cancer Genome Atlas data to identify and prioritize biomarkers retrospectively.

Main Results:

  • Simulation studies confirmed that predictive and prognostic biomarker subgroups can lead to time-dependent treatment effects in overall populations.
  • RTOG 9402 data analysis showed biomarker-specific effects (1p/19q co-deletion, IDH mutation) caused time-varying treatment effects and deviated from proportional hazards.
  • Statistical models successfully identified and prioritized a known biomarker through retrospective analysis of clinical trial data.

Conclusions:

  • Biomarkers that are both predictive and prognostic can create distinct survival patterns.
  • Retrospective analysis of clinical trial survival data can reveal potential underlying predictive biomarkers.